Target intelligence / Profile preview

Collagenase enzyme

Molecular classification
Enzyme, Metallopeptidase, Matrix metalloproteinase (for mammalian forms)
01

Overview

Collagenases are a family of zinc-dependent endopeptidases that specifically cleave peptide bonds within the triple-helical regions of collagens, the main structural proteins in animal connective tissues. They play essential roles in normal physiological processes like tissue remodeling, wound healing, and embryonic development. Pathologically, they contribute to bacterial virulence by degrading host barriers during infection (*e.g.*, gas gangrene caused by *Clostridium* species), facilitate tumor cell invasion through extracellular matrix breakdown, and participate in inflammatory tissue destruction. Therapeutically purified collagenases from bacteria (*e.g.*, *Clostridium histolyticum*) are approved for enzymatic treatment of fibrotic disorders such as Dupuytren's contracture and Peyronie's disease. Mammalian homologues belong primarily to the matrix metalloproteinases family.[1][2][4] Note: The term “Collagenase enzyme family” encompasses multiple distinct enzymes with different sources and substrate specificities; for precise targeting or drug discovery purposes it is important to specify which member(s) are intended.[6][3]

Other names
CollagenasesMicrobial collagenaseClostridium histolyticum collagenaseMatrix metalloproteinases (MMPs) (for mammalian forms)Clostridiopeptidase AGelatinase ColG[3][1]
02

Mechanism of action

Proteolytic cleavage of triple-helical regions in native collagen molecules, leading to breakdown of the extracellular matrix[2][3]

03

Biological functions

Degradation of extracellular matrix proteins (collagen breakdown)Tissue remodeling and repairFacilitation of bacterial invasion in pathogenesis[1][2]
04

Disease associations

Cancer (tumor invasion and metastasis via matrix degradation)Inflammation (tissue destruction in inflammatory diseases)Infection (bacterial spread, e.g., gas gangrene by *Clostridium* species)[1]
05

Safety considerations

Excessive tissue degradation leading to unwanted side effects such as delayed wound healing or tissue necrosis.Allergic reactions or immune responses when using microbial-derived enzymes therapeutically.Off-target proteolysis affecting non-collagen substrates.[1]
06

Interacting drugs

Collagenase clostridium histolyticum (Xiaflex) – used for Dupuytren's contracture and Peyronie's disease[1]
07

Biomarkers

Matrix metalloproteinases such as MMP9 are used as biomarkers for tissue remodeling and some cardiovascular diseases[4]

Beyond the preview

Go deeper on Collagenase enzyme.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Collagenase enzyme.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call